🇺🇸 FDA

Drug profile · INN

decamethonium bromide

SYNCURINE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

decamethonium bromide (SYNCURINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN decamethonium bromide
Brand SYNCURINE
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is decamethonium bromide?

decamethonium bromide (SYNCURINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for decamethonium bromide?

SYNCURINE is a marketed brand name for decamethonium bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of decamethonium bromide?

decamethonium bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.